Loading insider details...
Beta
Latest Form 4 (May 6, 2026): Conversion of 4,180,550 COAG shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 6, 2026 | Hemab Therapeutics Holdings, Inc. (COAG) | Conversion | 4,180,550 | n/a |
| May 5, 2026 | Avalyn Pharma Inc. (AVLN) | Conversion | 3,327,734 | n/a |
| Oct 30, 2025 | MapLight Therapeutics, Inc. (MPLT) | Conversion | 2,733,681 | n/a |
| Jul 27, 2024 | IO Biotech, Inc. (IOBT) | Sale | 51,522 | $68.3K |
| May 15, 2024 | IO Biotech, Inc. (IOBT) | Sale | 658,809 | $802.5K |
| Mar 26, 2024 | SPRUCE BIOSCIENCES, INC. (SPRB) | Sale | 465,021 | $351.0K |
| Mar 21, 2024 | SPRUCE BIOSCIENCES, INC. (SPRB) | Sale | 842,020 | $647.0K |
| Mar 19, 2024 | SPRUCE BIOSCIENCES, INC. (SPRB) | Sale | 1,912,316 | $1.70M |
| Feb 16, 2024 | Metagenomi, Inc. (MGX) | Purchase | 100,000 | $1.02M |
| Feb 14, 2024 | IO Biotech, Inc. (IOBT) | Sale | 658,809 | $988.4K |